Posted by Michael Wonder on 14 Apr 2017
Fast start for FDA drug approvals in 2017
12 April 2017 - The US FDA is poised to make a comeback from the relatively low number of new drugs approved in 2016, though it's unlikely to match the approval highs from 2014 and 2015.
Already in 2017, FDA has approved 14 new drugs, though that quick pace is not likely to continue and the rest of the year is shaping up to be an average or slightly above average year for approvals.
Based on data from BioPharmCatalyst, FDA has just over 20 remaining applications for new drugs and biologics with review goal dates in 2017 and FDA is unlikely to approve much more than 30 new drugs in 2017.
